ADCYAP1 and cystic fibrosis: Our results demonstrate the potent antibacterial activity of PACAP38 against various bacterial strains, helping us identify a lead template, i. e. PACAP(9–38), that appears to be specific against Burkholderia cenocepacia, an epidemic pathogen of cystic fibrosis patients.